Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...

Infectious meningoencephalitis, characterized by inflammation of both the brain and adjacent meninges, is caused by a variety ...

Learn how to manage musculoskeletal pain in multiple sclerosis. Discover causes, symptoms, diagnosis, and effective treatment ...

Gait disturbances are a prevalent issue in individuals with neurological disorders, affecting millions worldwide. These disorders, including Parkinson's ...

This valuable study demonstrates that self-motion strongly affects neural responses to visual stimuli, comparing humans moving through a virtual environment to passive viewing. However, evidence that ...